Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease.
about
Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Addition of hydrochlorothiazid ...... s with chronic kidney disease.
@en
Addition of hydrochlorothiazid ...... s with chronic kidney disease.
@nl
type
label
Addition of hydrochlorothiazid ...... s with chronic kidney disease.
@en
Addition of hydrochlorothiazid ...... s with chronic kidney disease.
@nl
prefLabel
Addition of hydrochlorothiazid ...... s with chronic kidney disease.
@en
Addition of hydrochlorothiazid ...... s with chronic kidney disease.
@nl
P2093
P2860
P356
P1476
Addition of hydrochlorothiazid ...... s with chronic kidney disease.
@en
P2093
Daisuke Fuwa
Hiroyuki Kobori
Makoto Michikawa
Masashi Mizuno
Michio Fukuda
Nobuyuki Ohte
Sumiko Abe-Dohmae
Toshiyuki Miura
Yoshiaki Ogiyama
P2860
P304
1470320316652032
P356
10.1177/1470320316652032
P577
2016-04-01T00:00:00Z